< Back to latest news & events

News

KTN Microbiome Strategic Roadmap

February 2021

Event date: 29th January 2021

KTN Microbiome Strategic Roadmap is now live. The roadmap reviews the landscape of microbiome science and innovation within the UK. The main objective of this document is to raise the visibility of the UK’s world leading microbiome science and enable translation of this science to benefit academic institutions, start-ups, SMEs and larger established companies.

It is a collaborative effort of 74 leading academic and industry scientists, including HGF Partner Craig Thomson as author, supported with contribution from Michelle Davies and Dr Lauris Kemp.

There are 12 distinct sections within the report, which summarise the current state of microbiome research, business and growth opportunities within each sector:

  • Intestinal Microbiome Transfer
  • Live Biotherapeutic Products & other Therapeutic Modalities
  • Personal Care & Hygiene
  • Nutrition & Wellbeing
  • Animal Health & Nutrition
  • AgriFood & Nutrition – Crop & Soil Health
  • Regulatory
  • Manufacturing
  • Biobanking
  • Enabling Technologies
  • Diagnostics
  • Intellectual property

Download the report here

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

IP Ingredients: The not so "Impossible" Burger

Meat alternatives are a hot topic with the increase in popularity of vegetarianism and veganism, highlighted by this month being “veganuary”.  However, at time when meat alternatives are coming under …

Read article

WTR 1000 2025

We are proud to announce that our European trade mark team has been recognised in the World Trade Mark Review 1000 2025. The firm is also proud to have 19 …

Read article

Court of Appeal Confirms No Second Medical Use SPCs in UK

Merck Serono SA  v  The Comptroller-General of Patents, Designs, and Trade Marks – Lewison LJ, Arnold LJ and Birss LJ – [2025] EWCA Civ 45 – 28 January 2025 The …

Read article

T 0295/22: Apremilast decision highlights hopes and challenges for broad second medical use claims

This case provides insight to the EPO’s interpretation of administration features in second medical use claims. Whilst the door appears to be open for broader second medical use claims, they …

Read article

T 1418/22: Acalabrutinib provides guidance on establishing inventiveness of polymorphs at the EPO

The EPO Board of Appeal’s decision in T 1418/22 gives useful guidance on the inventiveness of polymorph claims in Europe. Starting from a known amorphous form, a specific crystalline form …

Read article

HGF Celebrates Two Nominations at the Women and Diversity in Law Awards

We are proud to share that we have been nominated for two awards at The Women and Diversity in Law Awards which will take place on 18th March at Hilton …

Read article
See all updates